An overactive bladder (OAB) is a condition characterized by urinary urgency and frequency, which can have a significant impact on a person’s quality of life. An overactive bladder is caused by abnormal contractions of the bladder muscle, which results in the sudden urge to urinate and the inability to hold urine for a normal amount of time.
The main symptom of an overactive bladder is urinary urgency and frequency. This means that a person feels an almost uncontrollable urge to urinate and may have to go to the bathroom many times throughout the day and night. Other symptoms include waking up frequently to urinate at night, leaking urine, and feeling the need to urinate without having the urge to do so.
The exact cause of overactive bladder is not clear, but it is believed to be related to an imbalance of certain chemicals in the body that control bladder function. Factors that can be associated with the condition include aging, neurological diseases such as stroke and multiple sclerosis, bladder infections, and certain medications.
Myrbetriq is a prescription medication used to treat symptoms of overactive bladder. It is one of the most expensive medications on the market today and has been the subject of much debate over the cost.
The cost of Myrbetriq is due to several factors, including the fact that it is a brand-name medication, the cost of its active ingredient, and the cost of research and development.
Myrbetriq is a brand-name medication. This means that it is only manufactured by one company, which has exclusive rights to the drug. This allows the company to set the price, and since it is the only option available, they can charge a premium.
The active ingredient in Myrbetriq is mirabegron, which is a relatively new drug. This means that it had to go through the expensive process of clinical trials and regulatory approval. This cost is then passed on to the consumer, making the medication more expensive.
Finally, the cost of research and development for Myrbetriq is also high. Developing new medications is a long and expensive process, and the cost is passed on to the consumer. This cost includes the cost of clinical trials, the cost of regulatory approval etc. Now, you know why is Myrbetriq so expensive.